Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors.
Nicholas GulatiDouglas DonnellyYingzhi QianUna MoranPaul JohannetJudy ZhongIman OsmanPublished in: Journal of translational medicine (2020)
The patient data used in this manuscript come from patients who were prospectively enrolled in two institutional review board-approved databases at NYU Langone Health (institutional review board #10362 and #S16-00122).